The June 15, 2018 issue of GEN is now available for viewing.

View email in a browser   |   Forward to a Colleague

Table of Contents Alert

June 15, 2018 

Molecular Diagnostics Brings Patients Hope

Feature Image

Advancements in next-generation sequencing pave the way for researchers to discover more about the pathways of drug resistance.

More
 

  GEN Webinar

  Lighting Up the Heart

Graphene plates use light-induced electricity to make cardiomyocytes “beat.”

 Single-Cell Analysis for a More Perfect Cell Biology

Sometimes less is more as honing in on a single cell, instead of a group, grants new insights.

 President Trump Reveals Plan to Cut Drug Prices

The President wants to make what he calls the injustice of high drug prices one of his top priorities. His plan, however, is not without controversy.

 

GEN eBook

 New Cell Signaling Pathways Mapped

Cell signaling to aid cartographers of cardiovascular disease.

 Disrupting Downstream Bottlenecks

Upstream innovations leave little time for downstream operations to catch a breather.

 Top 10 Under 40

Excellence plus youth equals a persistent stream of significant contributions to the biopharma field.

 Prevent Cancer Immunotherapy’s Side Effects

Autoantibodies are essential for profiling patients to discern immunotherapy treatment efficacy.

 Phoseon Technology’s UV LEDs Detect and Disinfect

The electromagnetic spectrum has nothing on the spectrum of applications of UV light in the lab.

 Validating Anti-Idiotypic Binders for Trastuzumab

Avacta intends to allow for enhanced accuracy via Affimer reagents.

 Developing Detection Tools for Gasdermin E

Programmed cell death involving GSDME appears to exacerbate the adverse side effects of chemotherapy.

 Elemental Packing for Downstream Processing

Pack it up and pack it in because the wave of elemental packing is about to begin.

 
About GEN Advertising Editorial Business and Partnership Opportunities
 
GEN Cover
 

 


Current Issue

Genetic Engineering & Biotechnology News (GEN) has retained its position as the premier biotech publication since its launch in 1981. GEN publishes a print edition 21 times a year and has additional exclusive editorial content online, including news and analysis as well as webinars, videos, and polls. GEN's unique news and technology focus covers the entire bioproduct life cycle, including drug discovery, early-stage R&D, applied research (e.g., omics, biomarkers, and diagnostics), bioprocessing, and commercialization.


This email was sent by:
Genetic Engineering & Biotechnology News
Mary Ann Liebert, Inc., publishers
140 Huguenot Street, New Rochelle, NY 10801, USA

MANAGE e-SUBSCRIPTIONS

Update All Email Preferences  |  View GEN Privacy Policy

You have received this email at @{delivery_email}@.
IMPORTANT! Make sure you receive your chosen GEN eNewsletters.
Add [email protected] to your Address Book or Safe Senders List. It's easy! Click HERE for instructions.

Unsubscribe from GEN TOC Alert